Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells

This publication has 41 references indexed in Scilit:

• 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
  2000
• Seocalcitol (EB 1089) A Vitamin D Analogue of Anti-cancer Potential. Background, Design, Synthesis, Pre-clinical and Clinical Evaluation
  Current Pharmaceutical Design, 2000
• 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence
  Molecular and Cellular Biology, 2000
• Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells
  European Journal Of Cancer, 1999
• Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17β-Estradiol in Breast Cancer Cells
  Journal of Biological Chemistry, 1999
• EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro
  British Journal of Pharmacology, 1998
• Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells
  European Journal Of Cancer, 1993
• Effect of Estrogen and Antiestrogens on Cell Proliferation and Synthesis of Secreted Proteins in the Human Breast Cancer Cell Line MCF-7 and a Tamoxifen Resistant Variant Subline, AL-1
  Acta Oncologica, 1992
• Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines
  British Journal of Cancer, 1986
• The value of estrogen and progesterone receptors in the treatment of breast cancer
  Cancer, 1980